EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Copper ion incorporation in α‐synuclein amyloids

Gulshan Walke, Ranjeet Kumar, Pernilla Wittung-Stafshede iD

Protein Science · 2024-04 · 33 (4)

DOI: 10.1002/pro.4956 ↗

At a glance

Journal article in Protein Science, published online on 2024-03-21. Written by Gulshan Walke and 2 co-authors. Institution: Department of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden. Major MEDLINE topics: alpha-Synuclein, Parkinson Disease. Cited 23 times so far (Crossref); 65 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Vetenskapsrådet, Knut och Alice Wallenbergs Stiftelse.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Copper ion dys‐homeostasis is linked to neurodegenerative diseases involving amyloid formation. Even if many amyloidogenic proteins can bind copper ions as monomers, little is known about copper interactions with the resulting amyloid fibers. Here, we investigate copper interactions with α‐synuclein, the amyloid‐forming protein in Parkinson's disease. Copper (Cu(II)) binds tightly to monomeric α‐synuclein in vitro involving the N‐terminal amine and the side chain of His50. Using purified protein and biophysical methods in vitro, we reveal that copper ions are readily incorporated into the formed amyloid fibers when present at the start of aggregation reactions, and the metal ions also bind if added to pre‐formed amyloids. Efficient incorporation is observed for α‐synuclein variants with perturbation of either one of the high‐affinity monomer copper‐binding residues (i.e., N‐terminus or His50) whereas a variant with both N‐terminal acetylation and His50 substituted with Ala does not incorporate any copper into the amyloids. Both the morphology of the resulting α‐synuclein amyloids (amyloid fiber pitch, secondary structure, proteinase sensitivity) and the copper chemical properties (redox activity, chemical potential) are altered when copper is incorporated into amyloids. We speculate that copper chelation by α‐synuclein amyloids contributes to the observed copper dys‐homeostasis (e.g., reduced bioavailable levels) in Parkinson's disease patients. At the same time, amyloid‐copper interactions may be protective to neuronal cells as they will shield aberrantly free copper ions from promotion of toxic reactive oxygen species.

Subjects

MeSH terms (MEDLINE)

alpha-SynucleinParkinson DiseaseHumansCopperAmyloidAmyloidogenic ProteinsIons

Author keywords

aggregationalpha‐synucleinamyloidcopperreactive oxygen species

Substances

alpha-SynucleinCopperAmyloidAmyloidogenic ProteinsIons

Authors and institutions

  • Department of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden.

ORCID profiles: Pernilla Wittung-Stafshede

Funding

  • Vetenskapsrådet
  • Knut och Alice Wallenbergs Stiftelse

Cite

APA

Walke, G., Kumar, R., & Wittung-Stafshede, P. (2024). Copper ion incorporation in α‐synuclein amyloids. Protein Science, 33(4). https://doi.org/10.1002/pro.4956

Vancouver

Walke G, Kumar R, Wittung-Stafshede P. Copper ion incorporation in α‐synuclein amyloids. Protein Science. 2024;33(4). doi:10.1002/pro.4956

BibTeX
@article{Walke2024,
  author = {Walke, Gulshan and Kumar, Ranjeet and Wittung-Stafshede, Pernilla},
  title = {Copper ion incorporation in α‐synuclein amyloids},
  journal = {Protein Science},
  year = {2024},
  volume = {33},
  number = {4},
  doi = {10.1002/pro.4956}
}
Start for free →